MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 12-16-2024
Enzo Biochem Operating Cash Flow 2011-2026 | ENZ
Annual Operating Cash Flow Enzo Biochem
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -26.3 M | -37 M | -16.6 M | 387 K | -17.2 M | 4.81 M | -2.74 M | -205 K | 53.1 M | -3.7 M | -1.7 M | -10 M | -5.97 M | -8.33 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 53.1 M | -37 M | -5.1 M |
Quarterly Operating Cash Flow Enzo Biochem
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -8.99 M | - | - | - | -13.4 M | - | - | - | -8.69 M | - | - | - | -6.04 M | -2.03 M | - | - | -1.21 M | -7.99 M | -1.21 M | - | -2.07 M | -14.8 M | - | - | -6.2 M | 835 K | -6.2 M | - | 2.6 M | -2.83 M | 2.6 M | - | -333 K | 20.1 M | -333 K | - | 13.2 M | -6.47 M | 13.2 M | - | -2.76 M | -4.7 M | -2.76 M | - | -3.31 M | -4.57 M | -3.31 M | - | -1.48 M | -3.55 M | -1.48 M | - | -2.3 M | -2.18 M | -2.3 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 20.1 M | -14.8 M | -2.09 M |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Brainsway Ltd.
BWAY
|
884 K | $ 23.11 | 4.52 % | $ 99.4 M |  Israel |
 |
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
-478 M | $ 23.0 | 2.86 % | $ 248 M |  China |
 |
Castle Biosciences
CSTL
|
64.9 M | $ 39.93 | -1.67 % | $ 1.11 B | USA |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
DarioHealth Corp.
DRIO
|
-30.4 M | $ 12.98 | 6.97 % | $ 368 M | Israel |
 |
Fulgent Genetics
FLGT
|
21.1 M | $ 27.9 | -0.39 % | $ 844 M | USA |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
BioNano Genomics
BNGO
|
-68.9 M | $ 1.6 | -0.22 % | $ 2.03 M | USA |
 |
Co-Diagnostics
CODX
|
-22.1 M | $ 6.1 | 1.16 % | $ 179 M | USA |
 |
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | USA |
 |
Danaher Corporation
DHR
|
6.69 B | $ 234.99 | -0.25 % | $ 172 B | USA |
 |
DexCom
DXCM
|
748 M | $ 68.47 | -2.33 % | $ 26.4 B | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | China |
 |
Exact Sciences Corporation
EXAS
|
211 M | $ 101.77 | 0.14 % | $ 18.9 B | USA |
 |
Mettler-Toledo International
MTD
|
968 M | $ 1 461.94 | -0.56 % | $ 31 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-8.7 M | $ 6.63 | -0.08 % | $ 601 M | USA |
 |
CareDx, Inc
CDNA
|
-18.4 M | $ 17.5 | -7.41 % | $ 941 M | USA |
 |
National Research Corporation
NRC
|
38.1 M | $ 19.66 | 4.02 % | $ 482 M | USA |
 |
Celcuity
CELC
|
-83.5 M | $ 105.54 | -3.33 % | $ 4.16 B | USA |
 |
Natera
NTRA
|
-432 M | $ 237.86 | -6.5 % | $ 23.4 B | USA |
 |
OPKO Health
OPK
|
-183 M | $ 1.37 | 0.37 % | $ 951 M | USA |
 |
Anixa Biosciences
ANIX
|
-7.34 M | $ 3.4 | 3.66 % | $ 108 K | USA |
 |
Guardant Health
GH
|
-240 M | $ 107.75 | -1.98 % | $ 13.2 B | USA |
 |
Personalis
PSNL
|
-45.2 M | $ 8.36 | -10.64 % | $ 495 M | USA |
 |
QIAGEN N.V.
QGEN
|
674 M | $ 48.19 | 1.71 % | $ 10.7 B |  Niderland |
 |
Aspira Women's Health
AWH
|
-32.2 M | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
2.72 B | $ 243.4 | -0.36 % | $ 44.1 B | USA |
 |
Illumina
ILMN
|
837 M | $ 146.41 | -2.48 % | $ 23.3 B | USA |
 |
Charles River Laboratories International
CRL
|
735 M | $ 214.0 | -1.51 % | $ 11 B | USA |
 |
Thermo Fisher Scientific
TMO
|
8.67 B | $ 605.45 | -1.87 % | $ 231 B | USA |
 |
Trinity Biotech plc
TRIB
|
13.2 M | $ 0.75 | -1.33 % | $ 61.9 M |  Irlanda |
 |
Quest Diagnostics Incorporated
DGX
|
1.33 B | $ 177.06 | -0.64 % | $ 19.7 B | USA |
|
Biodesix
BDSX
|
-48.6 M | $ 5.77 | -3.27 % | $ 748 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.59 B | $ 254.76 | 0.43 % | $ 21.4 B | USA |
 |
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | Israel |
 |
Twist Bioscience Corporation
TWST
|
-47.6 M | $ 34.81 | -4.76 % | $ 2.08 B | USA |
 |
ICON Public Limited Company
ICLR
|
1.29 B | $ 189.39 | -6.67 % | $ 15.6 B | Irlanda |
 |
IDEXX Laboratories
IDXX
|
929 M | $ 708.9 | -0.79 % | $ 58.5 B | USA |
 |
Lantheus Holdings
LNTH
|
545 M | $ 68.27 | -1.59 % | $ 4.72 B | USA |